Prostate Cancer

News | Radiopharmaceuticals and Tracers | January 06, 2017

New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of prostate cancer...

MRI-guided focused ultrasound
News | Focused Ultrasound Therapy | December 22, 2016

Insightec Ltd. announced that the Exablate Prostate system received CE Mark for treating locally-confined prostate...

prostate, CT scan
News | Prostate Cancer | December 22, 2016

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics...

News | Prostate Cancer | December 14, 2016

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on small molecules that...

News | Prostate Cancer | December 09, 2016

Exact Imaging, a leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance...

prostate cancer, PET imaging, Johns Hopkins, Daniel Thorek, 11B6 antibody

Uptake of 89Zr-11B6 in the prostate of a transgenic mouse with prostate cancer. Image courtesy of Daniel Thorek

News | Prostate Cancer | November 30, 2016

An international group of researchers report success in mice of a method of using positron emission tomography (PET...

Augmenix, SpaceOAR System, prostate cancer, new CPT code, AMA, American Medical Association
Technology | Prostate Cancer | November 10, 2016

Augmenix Inc. announced that the American Medical Association (AMA) has granted a Category I, Current Procedural...

News | Prostate Cancer | November 02, 2016

November 2, 2016 — A new report on Swedish men with non-aggressive prostate cancer suggests a lot more American men...

Augmenix, SpaceOAR System, prostate cancer, three-year clinical data results, ASTRO 2016
News | Prostate Cancer | October 27, 2016

Augmenix Inc. announced the three-year results from the SpaceOAR System Prostate Cancer US Pivotal Clinical Trial in...

intermediate-risk prostate cancer, brachytherapy versus external beam therapy, radiation therapy, RT, ASTRO 2016
News | Brachytherapy Systems | October 25, 2016

For men with intermediate-risk prostate cancer, radiation treatment with brachytherapy alone can result in similar...

Axumin, fluciclovine F-18, PET agent, Phase 3 study, recurrent prostate cancer detection, Blue Earth Diagnostics
News | Prostate Cancer | October 25, 2016

Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3 clinical trial of...

prostate cancer, SBRT, stereotactic body radiotherapy, ASTRO 2016 study, Robert Meier, control, side effects, toxicity
News | Radiation Therapy | October 06, 2016

High-dose stereotactic body radiotherapy (SBRT) for men newly diagnosed with low- or intermediate-risk prostate...

prostate cancer, ProtecT trial findings, ASTRO 2016, radiation therapy
News | Radiation Therapy | October 03, 2016

The American Society for Radiation Oncology (ASTRO) extended its congratulations to the authors and investigators in...

prostate cancer, hormone therapy, cardiac risk factors, Yale Cancer Center study, ASTRO 2016
News | Cardio-oncology | September 28, 2016

In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer...

prostate cancer, hypofractionated radiationt therapy, accelerated RT, side effects, treatment time, ASTRO 2016, NRG Oncology/RTOG 0415
News | Prostate Cancer | September 27, 2016

September 27, 2016 — For men with early stage, low-risk...

prostate cancer, novel intrinsic subtypes, study, ASTRO 2016
News | Prostate Cancer | September 26, 2016

In the largest study of its kind to date, researchers have identified and validated three distinct molecular...

prostate cancer, hypofractionated radiation therapy, HYPO-RT-PC trial, ASTRO 2016
News | Prostate Cancer | September 26, 2016

September 26, 2016 — For men with intermediate-risk...

ASTRO 2016 annual meeting, clinical trials and research, press program, radiation therapy
News | Radiation Therapy | September 07, 2016

The American Society for Radiation Oncology (ASTRO) announced the press program for its 58th Annual Meeting, Sept....

Axumin, fluciclovine F-18 injection, first injection, Northside Hospital Atlanta
News | Radiopharmaceuticals and Tracers | September 07, 2016

September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S.

MRI, prostate cancer, zinc, UT Southwestern Medical Center study
News | Magnetic Resonance Imaging (MRI) | August 23, 2016

A novel magnetic resonance imaging (MRI) method that detects low levels of zinc ion can help distinguish healthy...

Overlay Init